10-Q Filing

BIO-TECHNE CORP CIK: 842023 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001193125-12-043543`
Period End Date	20111231
Filing Date	20120207
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	tech-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 72 Cash Flow Statement 70

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Trade accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$448.00K	USD	Point-in-time
Trade accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$450.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$94.14M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$135.88M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$80.99M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$77.61M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.15M	shares	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$56.76M	USD	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$63.20M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	36.89M	shares	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts of $450 and $448, respectively	`AccountsReceivableNetCurrent`	$35.91M	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts of $450 and $448, respectively	`AccountsReceivableNetCurrent`	$32.35M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	36.89M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.15M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$2.19M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.95M	USD	Point-in-time
Inventories	`InventoryNet`	$40.98M	USD	Point-in-time
Inventories	`InventoryNet`	$44.91M	USD	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetCurrent`	$5.80M	USD	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetCurrent`	$12.92M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.02M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.04M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$230.42M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$227.22M	USD	Point-in-time
Available-for-sale investments	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$131.99M	USD	Point-in-time
Available-for-sale investments	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$148.11M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$94.60M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$95.40M	USD	Point-in-time
Goodwill	`Goodwill`	$86.63M	USD	Point-in-time
Goodwill	`Goodwill`	$85.24M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$52.28M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$48.68M	USD	Point-in-time
Investments in unconsolidated entities	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$19.18M	USD	Point-in-time
Investments in unconsolidated entities	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$19.63M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.32M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.22M	USD	Point-in-time
Assets, Total	`Assets`	$624.25M	USD	Point-in-time
Assets, Total	`Assets`	$617.67M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$5.21M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$5.91M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$4.78M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$3.76M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.48M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.69M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$967.00K	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$5.51M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.12M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$12.62M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$13.36M	USD	Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 36,891,490 and 37,153,398, respectively	`CommonStockValue`	$369.00K	USD	Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 36,891,490 and 37,153,398, respectively	`CommonStockValue`	$371.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$129.31M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$130.52M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$472.73M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$487.52M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-20.90M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-16.29M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$597.51M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$586.12M	USD	Point-in-time
Liabilities and Equity, Total	`LiabilitiesAndStockholdersEquity`	$617.67M	USD	Point-in-time
Liabilities and Equity, Total	`LiabilitiesAndStockholdersEquity`	$624.25M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$67.71M	USD	1 Quarter
Net sales	`SalesRevenueNet`	$74.66M	USD	1 Quarter
Net sales	`SalesRevenueNet`	$135.65M	USD	2 Qtrs
Net sales	`SalesRevenueNet`	$152.26M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$19.49M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$30.68M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$15.33M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$38.70M	USD	2 Qtrs
Gross margin	`GrossProfit`	$104.98M	USD	2 Qtrs
Gross margin	`GrossProfit`	$55.17M	USD	1 Quarter
Gross margin	`GrossProfit`	$52.38M	USD	1 Quarter
Gross margin	`GrossProfit`	$113.56M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$16.04M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$21.42M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$10.65M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.43M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$6.60M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$13.50M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$13.22M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$6.84M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$15.03M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$17.49M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$34.93M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$29.26M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$37.68M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$37.35M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$78.63M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$75.71M	USD	2 Qtrs
Interest income	`InvestmentIncomeNet`	$1.02M	USD	1 Quarter
Interest income	`InvestmentIncomeNet`	$1.87M	USD	2 Qtrs
Interest income	`InvestmentIncomeNet`	$1.53M	USD	2 Qtrs
Interest income	`InvestmentIncomeNet`	$798.00K	USD	1 Quarter
Other non-operating expense, net	`OtherNonoperatingIncomeExpense`	$-955.00K	USD	2 Qtrs
Other non-operating expense, net	`OtherNonoperatingIncomeExpense`	$-698.00K	USD	1 Quarter
Other non-operating expense, net	`OtherNonoperatingIncomeExpense`	$-607.00K	USD	1 Quarter
Other non-operating expense, net	`OtherNonoperatingIncomeExpense`	$-1.78M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$191.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$912.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-256.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$322.00K	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$78.37M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$37.67M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$37.87M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$76.63M	USD	2 Qtrs
Income taxes	`IncomeTaxExpenseBenefit`	$12.06M	USD	1 Quarter
Income taxes	`IncomeTaxExpenseBenefit`	$11.14M	USD	1 Quarter
Income taxes	`IncomeTaxExpenseBenefit`	$25.04M	USD	2 Qtrs
Income taxes	`IncomeTaxExpenseBenefit`	$23.72M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$53.33M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$52.91M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$25.81M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$26.53M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.72	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.43	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$1.44	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.70	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.42	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.71	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.70	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.44	USD	2 Qtrs
Cash dividends per common share:	`CommonStockDividendsPerShareCashPaid`	$0.27	USD	1 Quarter
Cash dividends per common share:	`CommonStockDividendsPerShareCashPaid`	$0.53	USD	2 Qtrs
Cash dividends per common share:	`CommonStockDividendsPerShareCashPaid`	$0.28	USD	1 Quarter
Cash dividends per common share:	`CommonStockDividendsPerShareCashPaid`	$0.55	USD	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.07M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.09M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.03M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	36.97M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.13M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.10M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.16M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.03M	shares	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`NetIncomeLoss`	$53.33M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$52.91M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$25.81M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$26.53M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.06M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.31M	USD	2 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	-	USD	2 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$3.92M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-7.47M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$1.35M	USD	2 Qtrs
Stock-based compensation expense	`StockOptionPlanExpense`	$850.00K	USD	2 Qtrs
Stock-based compensation expense	`StockOptionPlanExpense`	$714.00K	USD	1 Quarter
Stock-based compensation expense	`StockOptionPlanExpense`	$858.00K	USD	1 Quarter
Stock-based compensation expense	`StockOptionPlanExpense`	$1.15M	USD	2 Qtrs
Excess tax benefit from stock option exercises	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$413.00K	USD	2 Qtrs
Excess tax benefit from stock option exercises	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$13.00K	USD	2 Qtrs
Losses by equity method investees	`IncomeLossFromEquityMethodInvestments`	$-415.00K	USD	2 Qtrs
Losses by equity method investees	`IncomeLossFromEquityMethodInvestments`	$-547.00K	USD	2 Qtrs
Other	`OtherNoncashIncomeExpense`	$-183.00K	USD	2 Qtrs
Other	`OtherNoncashIncomeExpense`	$-108.00K	USD	2 Qtrs
Trade accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-1.16M	USD	2 Qtrs
Trade accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-1.26M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$929.00K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$234.00K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-7.00K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-27.00K	USD	2 Qtrs
Trade accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.44M	USD	2 Qtrs
Trade accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-842.00K	USD	2 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-417.00K	USD	2 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-253.00K	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-4.40M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$956.00K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$54.87M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$60.14M	USD	2 Qtrs
Purchase of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$80.59M	USD	2 Qtrs
Purchase of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$84.04M	USD	2 Qtrs
Proceeds from sales of available-for-sale investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$39.09M	USD	2 Qtrs
Proceeds from sales of available-for-sale investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$55.35M	USD	2 Qtrs
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$36.94M	USD	2 Qtrs
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$24.43M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.30M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.76M	USD	2 Qtrs
Distribution from unconsolidated entity	`ProceedsFromReturnOfCapitalFromInterestInAffiliates`	$42.00K	USD	2 Qtrs
Distribution from unconsolidated entity	`ProceedsFromReturnOfCapitalFromInterestInAffiliates`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.58M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.28M	USD	2 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$19.64M	USD	2 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$20.39M	USD	2 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$45.00K	USD	2 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$3.43M	USD	2 Qtrs
Excess tax benefit from stock option exercises	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$413.00K	USD	2 Qtrs
Excess tax benefit from stock option exercises	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$13.00K	USD	2 Qtrs
Purchase of common stock for stock bonus plans	`PurchaseOfCommonStockForStockBonusPlans`	$294.00K	USD	2 Qtrs
Purchase of common stock for stock bonus plans	`PurchaseOfCommonStockForStockBonusPlans`	$907.00K	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$1.94M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$17.75M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-38.98M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-18.03M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.21M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.23M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$41.74M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.38M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$94.14M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$135.88M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$80.99M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$77.61M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$94.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$135.88M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$80.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$77.61M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.